Literature DB >> 7871003

Similar ameliorating effects of benzomorphans and 5-HT2 antagonists on drug-induced impairment of passive avoidance response in mice: comparison with acetylcholinesterase inhibitors.

K Matsuno1, T Senda, K Matsunaga, S Mita, H Kaneto.   

Abstract

Mice were trained to avoid electric shocks by means of step-down type passive avoidance learning tasks, and memory retention was measured 24 h after the training session. Memory impairment (amnesia) was produced by administering either p-chloroamphetamine (PCA), a serotonin (5-HT) releaser or scopolamine (SCOP), a muscarinic cholinoceptor antagonist, 30 min prior to the training session. Benzomorphans, 5-HT2 antagonists and acetylcholinesterase (AChE) inhibitors were administered immediately after the training session. PCA- but not SCOP-induced amnesia was attenuated by the post-training administration of two benzomorphans, (+)N-allylnormetazocine ((+)SKF-10,047) and (+/- )pentazocine ((+/- )PTZ). Similarly, PCA-induced amnesia was reversed by the post-training administration of 5-HT2 antagonists, ritanserin (RIT) and mianserin (MIA), but SCOP-induced amnesia was not. However, the AChE inhibitors, tetrahydroaminoacridine (THA) and physostigmine (PHY) attenuated both PCA- and SCOP-induced amnesia when administered immediately after the training session. These results indicated that benzomorphans and 5-HT2 antagonists have antiamnestic effects in mice, as do AChE inhibitors. In addition, it is interesting that the patterns of ameliorating effect of benzomorphans were similar to those of 5-HT2 antagonists, which differ from those of AChE inhibitors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7871003     DOI: 10.1007/bf02247374

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  60 in total

1.  Naloxone enhancement of memory.

Authors:  R B Messing; R A Jensen; J L Martinez; V R Spiehler; B J Vasquez; B Soumireu-Mourat; K C Liang; J L McGaugh
Journal:  Behav Neural Biol       Date:  1979-11

2.  Effects of 5-HT2 receptor antagonist on cycloheximide-induced amnesia in mice.

Authors:  T Nabeshima; K Itoh; K Kawashima; T Kameyama
Journal:  Pharmacol Biochem Behav       Date:  1989-03       Impact factor: 3.533

3.  Pharmacological and autoradiographic discrimination of sigma and phencyclidine receptor binding sites in brain with (+)-[3H]SKF 10,047, (+)-[3H]-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine and [3H]-1-[1-(2-thienyl)cyclohexyl]piperidine.

Authors:  B L Largent; A L Gundlach; S H Snyder
Journal:  J Pharmacol Exp Ther       Date:  1986-08       Impact factor: 4.030

4.  Effects of NMDA receptor antagonists on passive avoidance learning and retrieval in rats and mice.

Authors:  N Venable; P H Kelly
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

5.  Differential effects of sigma and phencyclidine receptor ligands on learning.

Authors:  K W Jones; L M Bauerle; V J DeNoble
Journal:  Eur J Pharmacol       Date:  1990-04-10       Impact factor: 4.432

6.  Serotonin inhibits acetylcholine release from rat striatum slices: evidence for a presynaptic receptor-mediated effect.

Authors:  G Gillet; S Ammor; G Fillion
Journal:  J Neurochem       Date:  1985-12       Impact factor: 5.372

7.  Forebrain serotonin and avoidance learning: behavioural and biochemical studies on the acute effect of p-chloroamphetamine on one-way active avoidance learning in the male rat.

Authors:  S O Ogren
Journal:  Pharmacol Biochem Behav       Date:  1982-06       Impact factor: 3.533

8.  The acute effect of p-chloroamphetamine on the retention of fear conditioning in the rat: evidence for a role of serotonin in memory consolidation.

Authors:  T Archer; S O Ogren; C Johansson
Journal:  Neurosci Lett       Date:  1981-08-07       Impact factor: 3.046

9.  Influence of N-allyl-normetazocine on acetylcholine release from brain slices: involvement of muscarinic receptors.

Authors:  A Siniscalchi; P Cristofori; E Veratti
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-10       Impact factor: 3.000

10.  The antagonistic effects of naloxone on cycloheximide and anisomycin-induced amnesia.

Authors:  T Kameyama; T Nabeshima; T Kozawa
Journal:  Pharmacol Biochem Behav       Date:  1986-09       Impact factor: 3.533

View more
  10 in total

1.  The attenuation of learning impairments induced after exposure to CO or trimethyltin in mice by sigma (sigma) receptor ligands involves both sigma1 and sigma2 sites.

Authors:  T Maurice; V L Phan; Y Noda; K Yamada; A Privat; T Nabeshima
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

2.  Effects of penitrem A on rat's performances in passive avoidance and Morris water maze tests.

Authors:  O Deschaux; J C Bizot
Journal:  Mycopathologia       Date:  1997       Impact factor: 2.574

3.  Anti-amnesic effect of dimemorfan in mice.

Authors:  Hui-Hung Wang; Jyh-Wei Chien; Yueh-Ching Chou; Jyh-Fei Liao; Chieh-Fu Chen
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

Review 4.  The role of serotonin in memory: interactions with neurotransmitters and downstream signaling.

Authors:  Mohammad Seyedabadi; Gohar Fakhfouri; Vahid Ramezani; Shahram Ejtemaei Mehr; Reza Rahimian
Journal:  Exp Brain Res       Date:  2014-01-16       Impact factor: 1.972

5.  Regional differences of the effect of sigma receptor ligands on the acetylcholine release in the rat brain.

Authors:  T Kobayashi; K Matsuno; S Mita
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

Review 6.  Sigmar1's Molecular, Cellular, and Biological Functions in Regulating Cellular Pathophysiology.

Authors:  Richa Aishwarya; Chowdhury S Abdullah; Mahboob Morshed; Naznin Sultana Remex; Md Shenuarin Bhuiyan
Journal:  Front Physiol       Date:  2021-07-07       Impact factor: 4.566

7.  Effects of Pridopidine on Functional Capacity in Early-Stage Participants from the PRIDE-HD Study.

Authors:  Andrew McGarry; Mika Leinonen; Karl Kieburtz; Michal Geva; C Warren Olanow; Michael Hayden
Journal:  J Huntingtons Dis       Date:  2020

Review 8.  Revisiting the sigma-1 receptor as a biological target to treat affective and cognitive disorders.

Authors:  Kinga Sałaciak; Karolina Pytka
Journal:  Neurosci Biobehav Rev       Date:  2021-11-01       Impact factor: 8.989

9.  Pharmacology and therapeutic potential of sigma(1) receptor ligands.

Authors:  E J Cobos; J M Entrena; F R Nieto; C M Cendán; E Del Pozo
Journal:  Curr Neuropharmacol       Date:  2008-12       Impact factor: 7.363

10.  Dipentylammonium Binds to the Sigma-1 Receptor and Protects Against Glutamate Toxicity, Attenuates Dopamine Toxicity and Potentiates Neurite Outgrowth in Various Cultured Cell Lines.

Authors:  James M Brimson; Stephen T Safrany; Heider Qassam; Tewin Tencomnao
Journal:  Neurotox Res       Date:  2018-03-27       Impact factor: 3.911

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.